This is one of those rare ideas where I said "wait I minute, I DID think of that!"
But you know their IBM so they can get to the patent office. Anyways... here's the story.
"IBM has just submitted a patent application dubbed an “Adaptive System for Real-Time Behavioural Coaching and Command Intermediation”. The translation to human: IBM is developing artificial intelligence for toys that could help children stop or develop certain behaviours. Read on for IBM’s explanation…
“…to help a child who plays rough with other children the interaction data can include multiple interaction operations that can be performed by the interactive device for helping the child play less rough with other children. For example, one interaction operation can include an audible warning telling the child ‘to play nice’ in a strict tone of voice, whereas another interaction operation can include an audible warning that asks the child ‘would you like someone to do that to you’ in a softer tone of voice along with a visual cue as well.”
New diabetes drug TAK-875 into Phase Ⅲ clinical trials
ReplyDeleteTakeda company recently said its type 2 diabetes drug TAK-875 has entered the late stage clinical trials. The drug is a selective GPR40 (G-protein-coupled receptors belonging in one) agonist, with referral guide from fatty acids (FFAs) on β cell insulin secretion regulating role. Takeda said, TAK-875 is currently the world's first such drugs in late stage research into new drugs.
GPR40 agonist treatment of type 2 diabetes and the mechanism of action of sulfonylureas (such as Amaryl) different, it selectively improving glucose-dependent insulin secretion and reduce the risk of hypoglycemia.
The drug Ⅲ trial started in September in Japan, in the United States / Europe first term Ⅲ study in 140 hospitals recruited 450 cases can not be controlled by diet and exercise in patients with type 2 diabetes. The latter study's primary endpoint was at 24 weeks when the change in HbA1c, is expected to announce 2014 results.
Medchemexpress Can provide the above product,its website:www.medchemexpress.com
ENMD-2076 TARTARIC ACID
ENMD-2076
SNS-314
CCT129202
Hesperadin
PF-03814735
AT9283
GSK-1070916
MK-5108
Aurora A inhibitor I